VerbatimParliament, as it happens

Life Sciences: Research

Asked by Alan MakConservativeDepartment for Science, Innovation and TechnologyTabled Answered 6 June 2025UIN 54306

The question

To ask the Secretary of State for Science, Innovation and Technology, what assessment he has made of the potential impact of changes in levels of funding for medicines on life sciences research.

Answered by Feryal Clark

The Secretary of State for Science, Innovation and Technology is working closely with the Department of Health and Social Care on the current Mid Scheme Review for the Voluntary Scheme for branded medicines pricing, access and growth (VPAG) and is aware of the impact which funding of medicines could have on life sciences research. In addition, the upcoming Life Sciences Sector Plan will set out a bold vision to strengthen world-class R&D, attract global investment, and accelerate healthcare innovation to ensure the UK remains a strong place for life sciences research.

Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →

Open this question in Verbatim →

Every written question, searchable

155,000 questions tabled since the election, with the answer each department gave — and the ones still unanswered, with the clock running. Free to search.

Search written questions →Read on Verbatim